Advisory Board and Editors Immunology
Jeremiah J Gassensmith
Jeremiah's research focuses on several areas:
Development of stimuli responsive "smart" biomaterials
Creating new thermosalient molecular crystalline materials
Using metal-organic frameworks for native protein (i.e. drug) delivery
Supramolecular and macromolecular organic radical contrast agents as MRI sensors
Roi Gazit
Roi Gazit, PhD., is Principal Investigator of Hematopoietic Stem Cell (HSC) transcriptome laboratory at the Ben-Gurion University of the Negev, Israel. He is a member of the National Institute for Biotechnology in the Negev (NIBN), and the Center for Regenerative Medicine and Stem Cells at BGU. Roi earned a B.Sc. and M.Sc. in life science and developmental biology from the Hebrew University of Jerusalem. He obtained PhD. in immunology, under supervision of Ofer Mandelboim, studying NK-cell in vivo, including the generation of the first NK specific mouse model and elucidation of novel NK-cell abnormalities in human patients. He conducted postdoctoral studies at the Harvard Medical School, at Derrick J. Rossi laboratory, focusing on the identification and utilization of HSCs’ genes, including reprogramming of committed blood cells into HSCs using defined transcription-factors and generation of a novel HSC-reporter mouse. His laboratory at the Ben-Gurion University is studying HSCs’ transcriptome along normal development, during immune-challenges, and the direct reprogramming of adult blood cells into HSCs.
Delia Goletti
Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.
Melissa M Grant
Senior Lecturer in Biological Sciences, University of Birmingham, UK
Co-lead for the Periodontal Research Group (PRG)
Melissa graduated in 1997 with a BSc in Biochemistry and immediately took up a CASE Award (Du Pont) PhD in the laboratories of Dr Dennis Briggs, studying enzymes involved in the germination of wheat grain. These enzymes would ultimately be exploited in the improvement of animal feeds and in bread baking, allowing bread to rise more and yield a ‘fluffier’ loaf.
She was introduced to the field of proteomic research at the end of her PhD and subsequently went on to set up the proteomic laboratory of Prof Helen Griffiths at Aston University. Leading on from her interests in nutrition Melissa investigated the effects of vitamins C, E and folate on human health and disease, including cancer, Alzheimer’s and heart diseases. She analysed both human plasma samples and cell culture derived samples, generating a number of papers during this post doctoral research.
In 2005 she joined the School of Dentistry's Periodontal Research Group at the University of Birmingham as lead postdoctoral fellow on projects to assess how micronutrients could be used to improve oral health. She was appointed as lecturer in 2011 in Biological Sciences and has office and laboratory space in both the schools of dentistry and biosciences.
Fanglin Guan
Prof. Fanglin Guan is Dean at Xi'an Jiaotong University. He is engaged in the integrated biological research of complex diseases, including tumor microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumor cell vaccines, especially for the exploration of the mechanism of determining the biomarkers of complex diseases.
Maximiliano Gutierrez
Max studied biochemistry and molecular biology in Argentina. In 2005, he was awarded a PhD in cell biology where he focused on the interactions between intracellular pathogens and the autophagic pathway. After that, he was in Gareth Griffiths Laboratory at EMBL, Heidelberg, Germany as a postdoctoral fellow of the von Humboldt foundation and EMBO focusing on the cell biology of macrophages and mycobacteria. In 2009, he became the head of the Junior Research Group “Phagosome Biology” at the Helmholtz Centre for Infection Research in Braunschweig, Germany. In 2012, he was recruited as a Programme Leader Track at the National Institute for Medical Research in London. Since 2015, he is a group leader at the Francis Crick Institute in London where he is developing imaging technologies and cellular models of infection to investigate the host-pathogen interactions in tuberculosis.
Deniz Can Güven
Dr. Deniz Can Güven is a medical oncologist in the Department of Medical Oncology at Hacettepe University.
His primary research interest focuses on immuno-oncology.
James Harris
Group Leader in Arthritis and Lupus Research Group, Department of Medicine, Monash University. Interests in cytokine biology, inflammasomes, MIF, autophagy, inflammation, innate immunity, veterinary and comparative immunology.
Deputy Editor, Immunology and Cell Biology.
Review Editor, Frontiers in Immunology.
Editorial Board member, Arthritis Research & Therapy.
Thomas Hartung
Professor of Toxicology (Chair for Evidence-based Toxicology), Pharmacology, Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health, Baltimore, and University of Konstanz, Germany; Director of their Centers for Alternatives to Animal Testing (CAAT). Former Head of the European Center for the Validation of Alternative Methods (ECVAM), Ispra, Italy.
Jian He
Dr. He obtained her Ph.D. degree from a joint Ph.D. program in Jilin University and University of California, San Diego under Prof. Shu Chien which is the Academician of National Academy of Sciences, National Academy of Engineering, Institute of Medicine, and American Academy of Arts and Sciences of US. Dr. He then worked in Los Alamos National Laboratory (LANL) in the United States, Chinese Academy of Sciences and Shanghai Jiao Tong University in China. In 2019, Dr. He joined the Center for Single-Cell Omics in Shanghai Jiao Tong University School of Medicine as the core director of the genomics core.
Dr. He’s research focused on developing more sophisticated technology of single-cell multiple-omics analysis, using systems biology strategies to elucidate the underlying mechanism of major diseases, especially oncology and discover novel biomarkers, and AI Drug Screening. As of June. 2022, Dr. He has authored 60 high-quality scholarly articles including 25 first-authored and correspondence author papers, which have been extensively cited. Also, Dr. He has filed 15 patents. Also, she has been awarded research grants and awards from National Natural Science Foundation, China Postdoctoral Science Special Foundation, and so on. Dr. He was invited to contribute review articles by highly influential research journals in her field and give oral presentations at national and international conferences. Dr. He also serves as an article reviewer of numerous notable international journals.
Laura Hertel
Principal Investigator, Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, California, USA. Formerly Assistant Professor in Molecular Virology, Department of Microbiology and Immunology, University of Western Ontario, Ontario, Canada.
Branka Horvat
MD PhD,
Head of the team Immunobiology of Viral Infection;
Research in the field of interaction between the virus and the immune system